From: Role of microRNAs in obesity and obesity-related diseases
miRNA | Target/process | Reference |
---|---|---|
let-7 | FABP4 and PPARγ signaling pathway. Antiregulates clonal expansion via HMGA2 | [74] |
miR-15a | Delta-like 1 homolog | [190] |
miR-22 | HDAC6 | [191] |
miR-27a/b | MAPK/ERK signaling via PHB, C/EBPβ, PPARγ, and aP2 signaling. Attenuates lipid accumulation | [65] |
miR-31 | C/EBPα signaling. | [192] |
miR-33b | Decrease lipogenesis via early B cell factor 1 (EBF1) targeting C/EBPα and PPARγ signaling | [193] |
miR-93 | Sirt7 and Tbx3 | [194] |
miR-125a | ERRα | [195] |
miR-130 | Inhibition of adipogenesis by inhibiting PPARγ | [66] |
miR-138 | Inhibition of adipocyte differentiation via EID-1. Lipid droplet reduction | [196] |
miR-145 | Preadipocyte differentiation by targeting IRS1 | [197] |
miR-155 | C/EBPβ pathway | [198] |
mirR-193a/b | Adiponectin production in the adipose tissue. Induce myoblast differentiation into brown adipocytes | [199] |
miR-194 | Stimulates osteogenesis and inhibits adipogenesis via COUP-TFII | [200] |
miR-221 | Adiponectin signaling | [198] |
miR-222 | Glucose metabolism. Altered by insulin administration | [198] |
miR-224 | EGR2. Fatty acid metabolism | [201] |
miR-344 | GSK3β, activating the Wnt/β-catenin signaling pathway. Decreases triglyceride accumulation | [65] |
miR-363 | Inhibits adipocyte differentiation by targeting E2F3. Downregulates C/EBPα and PPARγ | [73] |
miR-365 | Brown fat differentiation | [202] |
miR-369 | FABP4. Adipogenic differentiation | [187] |
miR-448 | KLF5. Activation of serotonin receptors 5-HT2AR and 5-HT2CR | [203] |
miR-709 | GSK3ß of Wnt/ß-catenin signaling | [204] |